Kathleen A. Gilmartin is Director at U S PHYSICAL THERAPY INC /NV (USPH). They have made 9 open-market trades across 1 company since 2019, most recently 2026-05-19.
CIK 0001741732
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $988K since 2019, never a sale. Across 9 scored buys the stock is up 3.9% at ninety days, and 2.9 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| USPH | 27,092 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-05-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 56% | 33% | 56% |
| Avg Move | -0.8% | -1.9% | +3.9% |
| Alpha | -1.5% | -2.3% | +2.9% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| USPH | BUY | 2025-11-20 | 2025-11-24 | $69.00 | $276K | +1.7% | +8.8% | +13.2% |
| USPH | BUY | 2024-09-03 | 2024-09-03 | $86.09 | $172K | -3.1% | -7.4% | +13.9% |
| USPH | BUY | 2023-11-10 | 2023-11-13 | $82.34 | $82K | +4.0% | +9.9% | +14.2% |
| USPH | BUY | 2022-08-24 | 2022-08-26 | $81.71 | $82K | -7.0% | -11.1% | +1.5% |
| USPH | BUY | 2022-08-08 | 2022-08-09 | $92.26 | $55K | -7.4% | -13.9% | -3.4% |
| USPH | BUY | 2021-12-06 | 2021-12-08 | $94.21 | $94K | -2.5% | -3.8% | -0.9% |
| USPH | BUY | 2021-05-20 | 2021-05-21 | $116.67 | $117K | +2.6% | -3.9% | -9.0% |
| USPH | BUY | 2019-12-05 | 2019-12-06 | $114.00 | $57K | +0.4% | -1.4% | -8.4% |
| USPH | BUY | 2019-03-29 | 2019-04-01 | $105.17 | $53K | +4.3% | +5.9% | +13.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.